
### [NCIT:C39750](http://purl.obolibrary.org/obo/NCIT_C39750)
**Label:** Glioblastoma, IDH-Wildtype

**Subclasses:** [NCIT:C68702](http://purl.obolibrary.org/obo/NCIT_C68702) (Adult Giant Cell Glioblastoma), [NCIT:C114966](http://purl.obolibrary.org/obo/NCIT_C114966) (Childhood Giant Cell Glioblastoma), [NCIT:C9370](http://purl.obolibrary.org/obo/NCIT_C9370) (Adult Brain Stem Gliosarcoma), [NCIT:C68701](http://purl.obolibrary.org/obo/NCIT_C68701) (Adult Gliosarcoma), [NCIT:C3796](http://purl.obolibrary.org/obo/NCIT_C3796) (Gliosarcoma), [NCIT:C4325](http://purl.obolibrary.org/obo/NCIT_C4325) (Giant Cell Glioblastoma), [NCIT:C115365](http://purl.obolibrary.org/obo/NCIT_C115365) (Recurrent Childhood Gliosarcoma), [NCIT:C115363](http://purl.obolibrary.org/obo/NCIT_C115363) (Recurrent Childhood Giant Cell Glioblastoma), [NCIT:C131209](http://purl.obolibrary.org/obo/NCIT_C131209) (Recurrent Gliosarcoma), [NCIT:C114759](http://purl.obolibrary.org/obo/NCIT_C114759) (Childhood Brain Stem Gliosarcoma), [NCIT:C114968](http://purl.obolibrary.org/obo/NCIT_C114968) (Childhood Gliosarcoma), 

**Class expressions from DL-Learner:**

- Thing 54.60%
- [NCIT:C28082](http://purl.obolibrary.org/obo/NCIT_C28082) (Grade 4) 51.52%
- [NCIT:C14158](http://purl.obolibrary.org/obo/NCIT_C14158) (High Grade) 51.52%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C14161](http://purl.obolibrary.org/obo/NCIT_C14161) (Low Grade))) 51.52%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39811](http://purl.obolibrary.org/obo/NCIT_C39811) (t(5;11)(q35;q13)))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma))) 36.87%


